BioLineRx and Hemispherian report GLIX1 brain PK/PD data and dose GLIX1-C101 fourth cohortNov 16Clinical readoutAllarity TherapeuticsBioLineRx, Ltd.Updated
Eikon reports Q3 2026 results, ESMO oncology data and new prostate cancer INDNov 12Quarterly updateAkari Therapeutics PlcAtrium Therapeutics
Bicara reaches substantial enrollment in HPV-negative head and neck cancer trialNov 9Quarterly updateArriVent BioPharma, Inc.Bicara Therapeutics
Pfizer registers real-world observational study of marstacimab in hemophilia A and B patientsOct 9Weekly roundup, 8 itemsabrocitinibcyclophosphamide
Allarity completes stenoparib manufacturing campaign, gets key US patent and CLIA certificationAug 14Quarterly updateAllarity Therapeutics
NeOnc reports positive Phase 2a data for NEO100 in recurrent IDH1-mutant gliomaAug 12Clinical readoutNeonc Technologies, Inc.perillyl alcohol
NeOnc confirms August 12 topline readout for Phase 2a NEO100 glioma studyAug 10Quarterly updateNEO212Neonc Technologies, Inc.
Black Diamond reports Phase 2 silevertinib data, plans FDA meeting on pivotal pathAug 5Quarterly updateBlack Diamond Therapeutics, Inc.silevertinib